Welcome to our dedicated page for RadNet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RadNet's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RadNet's regulatory disclosures and financial reporting.
RadNet, Inc. filed a prospectus supplement to its automatic shelf registration statement to register for resale up to 34,069 shares of common stock. These shares are to be issued to certain See-Mode Sellers or their designees as the share component of milestone payments under a June 2, 2025 Share Purchase Agreement involving DH AI International Holdings, B.V., a wholly owned RadNet subsidiary. The company also filed a legal opinion from its Chief Legal Officer on the validity of the securities as an exhibit.
RadNet, Inc. is registering for resale up to 34,069 shares of common stock that are to be released and issued to former shareholders of See-Mode Technologies Pte. Ltd. as the share component of a contingent milestone payment under a June 2, 2025 share purchase agreement. These See-Mode Shares relate to a US$4,203,462.24 contingent amount tied to specified FDA 510(k) milestones for a breast ultrasound detection product and are being registered pursuant to contractual registration rights. No proceeds from any resale will go to RadNet; selling stockholders receive all proceeds while RadNet bears registration expenses.
RadNet is a U.S. diagnostic imaging provider with 442 centers as of June 30, 2026 and a growing Digital Health segment branded DeepHealth. For the six months ended June 30, 2026, Imaging Centers net revenues were $1,198 million, compared with $970 million in the prior-year period.
RTW Investments, LP and Roderick Wong, M.D. report beneficial ownership of 4,846,958 shares of RadNet, Inc. common stock, representing 6.2% of the class, based on 78,634,236 shares outstanding as of May 8, 2026.
Both reporting persons have shared voting and dispositive power over all 4,846,958 shares and no sole voting or dispositive power. The shares are directly held by certain RTW-managed funds, which have the right to receive dividends and sale proceeds on these shares.
RadNet, Inc. reported Q2 2026 revenue of $622.7 million, up from $498.2 million a year earlier, driven mainly by growth in commercial insurance and Medicare volumes and expanded imaging operations. Revenue for the first six months of 2026 was $1.20 billion versus $969.6 million in 2025.
Despite higher revenue, profitability was pressured. Q2 2026 net income attributable to common stockholders was $7.5 million, down from $14.5 million, and the first half showed a net loss of $25.9 million versus a $23.5 million loss a year earlier, reflecting higher operating costs, acquisition-related expenses, interest expense and foreign currency translation losses.
Operating cash flow remained strong at $173.1 million for the first half, but was more than offset by $434.5 million of investing outflows, including $315.7 million for acquisitions and significant capital spending. Debt increased to $1.34 billion, largely from incremental Barclays term loan borrowings. Total assets rose to $4.23 billion, with goodwill increasing to $1.12 billion following multiple imaging center acquisitions and the approximately $264.1 million purchase of AI company Gleamer SAS, which expands the Digital Health segment.
RadNet, Inc. reported strong second quarter 2026 growth, with Total Company Revenue of $622.7 million, up 25.0% from $498.2 million a year earlier, and record Adjusted EBITDA of $99.7 million, up 22.7%. Imaging Center segment Adjusted EBITDA margin rose to 16.1%, a 17 basis point improvement, aided by a shift toward higher-value advanced imaging, which grew 21.2% in aggregate and 9.6% on a same-center basis.
The Digital Health segment delivered $32.4 million in revenue, up 56.5%, while Adjusted EBITDA declined to $2.5 million due to increased growth investments. Digital Health Annual Recurring Revenue reached $105.5 million, up from $53.5 million a year earlier. Company cash was $726.3 million at June 30, 2026 and the Net Debt to Adjusted EBITDA Ratio was 1.8x.
GAAP net income attributable to common stockholders was $7.5 million (diluted EPS $0.10), down from $14.5 million ($0.19) in the prior-year quarter, reflecting items such as $6.6 million of acquisition costs and $3.4 million of debt restructuring losses. Adjusted earnings were $23.2 million or $0.29 per diluted share. RadNet raised 2026 Imaging Center guidance for revenue, Adjusted EBITDA and Free Cash Flow while reaffirming Digital Health guidance.
RadNet, Inc. director David L. Swartz reported an open-market sale of 2,699 shares of Common Stock at $53.89 per share. After this sale, he holds 177,013 shares directly. A separate entry shows 37,019 shares held indirectly through his spouse, reflecting additional family ownership.
RadNet, Inc. executive Cornelis Wesdorp, Pres & CEO, Digital Health, reported an open-market sale of 4,750 shares of Common Stock at $58.11 per share. After this transaction, he directly owns 69,075 shares, indicating he retains a substantial equity position in the company.
RadNet, Inc. President and CEO Howard G. Berger reported an insider transaction involving a small stock gift. On this Form 4, his spouse made a bona fide gift of 90 shares of RadNet common stock to her relatives' trusts, with no sale proceeds and a reported price of zero.
Following the reported transactions, Berger holds 498,405 shares of common stock directly, and his spouse holds 19,910 shares indirectly attributed to him. The filing reflects a routine, non-market transfer rather than an open‑market purchase or sale.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting securities related to Common stock for RDNT. The filing lists 4,750, a monetary figure of $269,372.50, and the number 78,634,236 with 06/16/2026 and NASDAQ as exchange details.
The filing also itemizes two compensation-related entries dated 10/01/2024 for 3,495 and 10/01/2025 for 1,255. The "Securities Sold During The Past 3 Months" row is present but contains no amounts in the excerpt.